octreotide for variceal bleed
Selected indexed studies
- Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. (Endoscopy, 2022) [PMID:36174643]
- Comprehensive approach to esophageal variceal bleeding: From prevention to treatment. (World J Gastroenterol, 2024) [PMID:39575399]
- Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis. (J Gastrointestin Liver Dis, 2021) [PMID:33723542]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Octreotide in variceal bleeding. (1994) pubmed
- Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. (2022) pubmed
- Comprehensive approach to esophageal variceal bleeding: From prevention to treatment. (2024) pubmed
- Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis. (2021) pubmed
- One versus five days of octreotide infusion for acute esophageal variceal bleeding: a randomized controlled trial. (2025) pubmed
- Octreotide therapy for variceal hemorrhage. (1993) pubmed
- AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. (2024) pubmed
- Octreotide for acute esophageal variceal bleeding: a meta-analysis. (2001) pubmed
- Octreotide for acute variceal bleeding. (2001) pubmed
- Absence of evidence is not evidence of absence. (1995) pubmed